Logo

AnPac Bio-Medical Science: Aidong Chen, Chris Yu, Sheng Liu, Chao Feng

Apr 11, 2022

Aidong Chen has joined AnPac Bio-Medical Science, a cancer screening and detection company with operations in the US and China, as CEO and chair of the board of directors. He replaces Chris Yu, Anpac's founder, who will retain a senior management role to focus on the company's growing China business. Chen is a practicing physician and researcher who has been affiliated with several hospitals, including Yijishan Hospital and Nanjing Medical University.

In addition, Sheng "Dorothy" Liu is joining AnPac's board of directors, replacing Chao Feng. Liu is the CEO of Zhongjintai Venture Capital, a VC firm in Shenzhen. She will be an independent director and join the compensation committee, as well as serve as chairperson of the nominating committee.

Breaking News
The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.